Parallel Advisors, LLC Biolife Solutions Inc Transaction History

Parallel Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	BUY	$10.81 - $22.96 $10,810 - $22,960	1,000 Added 1041.67%	1,096 $15,000
Q3 2023 Nov 13, 2023	BUY	$10.81 - $22.96 $10,810 - $22,960	1,000 Added 1041.67%	1,096 $15,000
Q2 2023 May 20, 2024	SELL	$17.19 - $24.34 $1,839 - $2,604	-107 Reduced 52.71%	96 $2,000
Q2 2023 Aug 04, 2023	SELL	$17.19 - $24.34 $1,839 - $2,604	-107 Reduced 52.71%	96 $2,000
Q1 2023 May 20, 2024	BUY	$17.67 - $26.07 $3,587 - $5,292	203 New	203 $4,000
Q1 2023 Apr 25, 2023	BUY	$17.67 - $26.07 $1,466 - $2,163	83 Added 69.17%	203 $4,000
Q4 2022 Feb 03, 2023	BUY	$16.95 - $25.07 $406 - $601	24 Added 25.0%	120 $2,000
Q2 2022 Aug 01, 2022	BUY	$10.54 - $24.2 $1,011 - $2,323	96 New	96 $1,000
Q2 2021 Aug 06, 2021	SELL	$29.51 - $44.62 $69,791 - $105,526	-2,365 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$32.95 - $44.24 $15,157 - $20,350	-460 Reduced 16.28%	2,365 $85,000
Q4 2020 Feb 02, 2021	BUY	$27.5 - $45.75 $77,687 - $129,243	2,825 New	2,825 $113,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.